Principal Financial Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.7M | Buy |
1,798,974
+331,101
| +23% | +$6.76M | 0.02% | 560 |
|
|
2025
Q1 | $29.4M | Buy |
1,467,873
+32,208
| +2% | +$645K | 0.02% | 629 |
|
|
2024
Q4 | $38.3M | Sell |
1,435,665
-102,855
| -7% | -$2.74M | 0.02% | 547 |
|
|
2024
Q3 | $43.9M | Buy |
1,538,520
+40,377
| +3% | +$1.15M | 0.02% | 508 |
|
|
2024
Q2 | $32.6M | Sell |
1,498,143
-34,329
| -2% | -$747K | 0.02% | 607 |
|
|
2024
Q1 | $33.9M | Sell |
1,532,472
-53,201
| -3% | -$1.18M | 0.02% | 623 |
|
|
2023
Q4 | $34.2M | Buy |
1,585,673
+103,503
| +7% | +$2.23M | 0.02% | 581 |
|
|
2023
Q3 | $25M | Buy |
1,482,170
+122,169
| +9% | +$2.06M | 0.02% | 690 |
|
|
2023
Q2 | $18.7M | Buy |
1,360,001
+72,854
| +6% | +$1,000K | 0.01% | 889 |
|
|
2023
Q1 | $29.2M | Buy |
1,287,147
+376,327
| +41% | +$8.55M | 0.02% | 634 |
|
|
2022
Q4 | $21.4M | Buy |
910,820
+475,080
| +109% | +$11.2M | 0.02% | 781 |
|
|
2022
Q3 | $11.4M | Buy |
435,740
+186,064
| +75% | +$4.85M | 0.01% | 1116 |
|
|
2022
Q2 | $5.48M | Buy |
249,676
+72,226
| +41% | +$1.59M | ﹤0.01% | 1522 |
|
|
2022
Q1 | $7.96M | Sell |
177,450
-5,217
| -3% | -$234K | 0.01% | 1496 |
|
|
2021
Q4 | $7.83M | Buy |
182,667
+12,851
| +8% | +$551K | ﹤0.01% | 1513 |
|
|
2021
Q3 | $11.3M | Buy |
169,816
+989
| +0.6% | +$65.8K | 0.01% | 1343 |
|
|
2021
Q2 | $12.4M | Buy |
168,827
+80,263
| +91% | +$5.89M | 0.01% | 1321 |
|
|
2021
Q1 | $6.06M | Buy |
88,564
+10,212
| +13% | +$699K | ﹤0.01% | 1605 |
|
|
2020
Q4 | $5.26M | Buy |
78,352
+50,052
| +177% | +$3.36M | ﹤0.01% | 1545 |
|
|
2020
Q3 | $1.46M | Buy |
28,300
+1,800
| +7% | +$92.6K | ﹤0.01% | 1801 |
|
|
2020
Q2 | $999K | Buy |
+26,500
| New | +$999K | ﹤0.01% | 1831 |
|